Tactile Medical to Release Fourth Quarter and Fisc

MINNEAPOLIS, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD ), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, today announced that fourth quarter and fiscal year 2016 financial results will be released after the market closes on February 27th.

Management will host a conference call at 5:00 p.m. Eastern Time on February 27th to discuss the results of the quarter and host a question and answer session. Those who would like to participate may dial 866-393-4306 (734-385-2616 for international callers) and provide access code 61792798. A live webcast of the call will also be provided on the investor relations section of the Company's website at Investors.tactilemedical.com.

For those unable to participate, a replay of the call will be available for two weeks at 855-859-2056 (404-537-3406 for international callers); access code 61792798. The webcast will be archived on the investor relations section of the Company's website.

About   Tactile Systems Technology, Inc.

Tactile Systems Technology, Inc. (“Tactile Medical”) is a leader in developing and marketing at-home therapy devices that treat chronic diseases such as lymphedema and venous ulcers. Our unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity-of-care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our efforts increase clinical efficacy, reduce overall healthcare costs, and improve the quality of life for patients with chronic conditions.

Investor Inquiries: Mike Piccinino, CFA Managing Director Westwicke Partners 433-213-0500